#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

hypotyreózy

Clinical Significance of Smaller Gaps Between Strengths of Levothyroxine Preparations in the Treatment of Hypothyroidism

23. 2. 2024 Source: Thyroid Disorders

Many levothyroxine preparations have relatively large intervals between doses (25 µg, 50 µg, and 75 µg), creating obstacles for some patients to achieve an optimal maintenance dose. The availability of tablets that allow for dosing in between these values facilitates precise and effective titration of levothyroxine doses, especially at the lower end of the spectrum.

stitna zlaza

Generic Substitution of Levothyroxine in Practice

The active ingredient levothyroxine is found in a significant number of medicinal products (MP) in…
22. 2. 2024 Source: Thyroid Disorders
Malobuněčný karcinom plic

Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer

Small cell lung cancer (SCLC) is the most aggressive type of lung tumor. Although it responds well…
22. 2. 2024 Source: Small Cell Lung Cancer
Karcinom prsu

Current Sequence of Treatment for Metastatic HER2+ Breast Cancer

In September 2023, experts from Miami Cancer Institute published their consensus statement on the…
22. 2. 2024 Source: Ovarian and Breast Cancer
Oko AI

Artificial Intelligence and Deep Learning as the Future of Glaucoma Diagnosis

Glaucoma represents a group of eye diseases characterized by changes to the optic nerve. It is the…
21. 2. 2024 Source: proLékaře.cz
MUDr. Zárubová FOTO

MUDr. Jana Zárubová: Experiences with buccal midazolam in real practice are positive and we can significantly improve patients' quality of life

Recently, it has emerged as an alternative to traditionally rectally administered diazepam for…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
Epilepsie_žena

IEC 2023: Key Challenges for Epilepsy Patients Include Status Epilepticus and Anxiety Management

Why is anxiety a significant issue for epilepsy patients? What do current insights say about the…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
MOZOG NEURON

Ocrelizumab in the Treatment of Multiple Sclerosis –⁠ 10-Year Data

Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current…
20. 2. 2024 Source: Neurology - Multiple Sclerosis
symptomatická léčba

Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM

Interim results of the MAVA-LTE study provide the latest data on the long-term safety and efficacy…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
farmakoterapie

Mavacamten in the Treatment of HCM in Patients Referred for Septal Reduction

Extended 56-week follow-up of patients with hypertrophic cardiomyopathy (HCM) resistant to current…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
1 19 20 21 22 23 168
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#